Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | IM |
COVID symptoms/ sore throat and cough; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID symptoms/ sore throat and cough) in a female patient of an unknown age who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. In September 2025, the patient experienced COVID-19 (COVID symptoms/ sore throat and cough). At the time of the report, COVID-19 (COVID symptoms/ sore throat and cough) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Oct-2025, SARS-CoV-2 test: confirmed. No concomitant medication was reported. The patient had COVID symptoms, including a sore throat and cough. She had received the COVID vaccine on 16-Sep-2025 and contracted COVID a week later, confirmed after taking a COVID test on Saturday. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. Reporter causality not provided.
Test Date: 20251004; Test Name: COVID test; Result Unstructured Data: confirmed